MSK-DA01 Cell Therapy

· BlueRock Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSK-DA01 Cell Therapy, covering 2024-11-01 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease [Phase 1]